Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clémence Basse

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Expert Review of Anticancer Therapy|August 22, 2022
<i>EGFR</i>-mutant NSCLC: monitoring the molecular evolution of tumors in 2022Nicolas Girard, Clémence Basse
European Respiratory Review : an Official Journal of the European Respiratory Society|October 21, 2021
Thymic tumours and their special featuresClémence Basse, Nicolas Girard
International Journal of Cancer|November 21, 2014
The increasing roles of epigenetics in breast cancer: Implications for pathogenicity, biomarkers, prevention and treatmentClémence Basse, Michel Arock
Frontiers in Oncology|February 7, 2022
Pembrolizumab Plus Chemotherapy in Metastatic Thymic Carcinoma: A Case ReportQuentin Dominique Thomas, Clémence Basse, Marie Luporsi, et al.
Lung Cancer (Amsterdam, Netherlands)|May 17, 2021
Impact of COVID-19 on the management of patients with thoracic cancers in a tertiary referral centerClémence Basse, Catherine Daniel, Alain Livartowski, et al.
Lung Cancer (Amsterdam, Netherlands)|October 5, 2022
Management of cutaneous toxicities under amivantamab (anti MET and anti EGFR bispecific antibody) in patients with metastatic non-small cell lung cancer harboring EGFR Exon20ins: towards a proactive, multidisciplinary approachClémence Basse, Hédi Chabanol, Pierre-Emmanuel Bonte, et al.
Lung Cancer (Amsterdam, Netherlands)|April 13, 2024
Management of sotorasib-related adverse events and hepatotoxicities following anti-PD-(L)1 therapy: Experience with sotorasib in two French anti-cancer centers and practical guidance proposalAli Chour, Clémence Basse, Fanny Lebossé, et al.
The Oncologist|June 24, 2022
Comprehensive Genomic Profiling of 274 Thymic Epithelial Tumors Unveils Oncogenic Pathways and Predictive BiomarkersNicolas Girard, Clémence Basse, Alexa Schrock, et al.
Bulletin Du Cancer|June 14, 2020
[Immunotherapy of metastatic non-small cell lung cancer from first line to resistance and its management]Clémence Basse, Aurelie Swalduz, Matteo Giaj Levra, et al.
Journal of Gynecology Obstetrics and Human Reproduction|September 30, 2023
Second-trimester medical abortion after exposure to lorlatinib during early pregnancy, a case reportMarie Mawet, Clémence Basse, Mathilde Barrois, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Expert Review of Anticancer Therapy|August 22, 2022
<i>EGFR</i>-mutant NSCLC: monitoring the molecular evolution of tumors in 2022Nicolas Girard, Clémence Basse
European Respiratory Review : an Official Journal of the European Respiratory Society|October 21, 2021
Thymic tumours and their special featuresClémence Basse, Nicolas Girard
International Journal of Cancer|November 21, 2014
The increasing roles of epigenetics in breast cancer: Implications for pathogenicity, biomarkers, prevention and treatmentClémence Basse, Michel Arock
Frontiers in Oncology|February 7, 2022
Pembrolizumab Plus Chemotherapy in Metastatic Thymic Carcinoma: A Case ReportQuentin Dominique Thomas, Clémence Basse, Marie Luporsi, et al.
Lung Cancer (Amsterdam, Netherlands)|May 17, 2021
Impact of COVID-19 on the management of patients with thoracic cancers in a tertiary referral centerClémence Basse, Catherine Daniel, Alain Livartowski, et al.
Lung Cancer (Amsterdam, Netherlands)|October 5, 2022
Management of cutaneous toxicities under amivantamab (anti MET and anti EGFR bispecific antibody) in patients with metastatic non-small cell lung cancer harboring EGFR Exon20ins: towards a proactive, multidisciplinary approachClémence Basse, Hédi Chabanol, Pierre-Emmanuel Bonte, et al.
Lung Cancer (Amsterdam, Netherlands)|April 13, 2024
Management of sotorasib-related adverse events and hepatotoxicities following anti-PD-(L)1 therapy: Experience with sotorasib in two French anti-cancer centers and practical guidance proposalAli Chour, Clémence Basse, Fanny Lebossé, et al.
The Oncologist|June 24, 2022
Comprehensive Genomic Profiling of 274 Thymic Epithelial Tumors Unveils Oncogenic Pathways and Predictive BiomarkersNicolas Girard, Clémence Basse, Alexa Schrock, et al.
Bulletin Du Cancer|June 14, 2020
[Immunotherapy of metastatic non-small cell lung cancer from first line to resistance and its management]Clémence Basse, Aurelie Swalduz, Matteo Giaj Levra, et al.
Journal of Gynecology Obstetrics and Human Reproduction|September 30, 2023
Second-trimester medical abortion after exposure to lorlatinib during early pregnancy, a case reportMarie Mawet, Clémence Basse, Mathilde Barrois, et al.
Pageof 3